Related Experiment Video
Updated: Jul 12, 2025

Phage Phenomics: Physiological Approaches to Characterize Novel Viral Proteins
Published on: June 11, 2015
Isolation, characterization, and genome analysis of novel bacteriophage - Stenotrophomonas phageCM1
Calmly M Koshy1, Shobana Sugumar1
1Department of Genetic Engineering, Faculty of Engineering and Technology, School of Bioengineering, SRM Institute of Science and Technology, SRM Nagar, Kattankulathur, Kanchipuram, Chennai, Tamil Nadu, 603203, India.
Abstract:
A common environmental bacteria called Stenotrophomonas maltophilia has become an organism responsible for significant nosocomial infection, mortality in immunocompromised patients, and significantly increasing morbidity and is challenging to treat due to the antibiotic resistance activity of the organism. and bacteriophage therapy is one of the promising treatments against the organism. In this research, we isolated, identified, and characterized Stenotrophomonas phage CM1 against S. maltophilia. Stenotrophomonas phage CM1 head was measured to have a diameter of around 224.25 nm and a tail length of about 159 nm. The phage was found to have noticeable elongated tail spikes around 125 nm in length, the Myoviridae family of viruses, which is categorized under the order Caudovirales. The ideal pH for growth was around 7, demonstrated good thermal stability when incubated at 37-60 °C for 30 min or 60 min, and phage infectivity decreased marginally after 30 min of incubation at 1-5% chloroform concentration. Phage was 3,19,518 base pairs long and had an averaged G + C composition of 43.9 %; 559 open-reading frames (ORFs) were found in the bacteriophage genome, in which 508 of them are hypothetical proteins, 22 of them are other known proteins, 29 of them are tRNAs, and one of them is restriction enzyme. A phylogenetic tree was reconstructed, demonstrating that CM1 shares a close evolutionary relationship with other Stenotrophomonas phages.
Insights
Researchers isolated and characterized Stenotrophomonas phage CM1, a promising bacteriophage therapy candidate effective against the antibiotic-resistant bacterium Stenotrophomonas maltophilia, offering new hope for treating nosocomial infections.
Area of Science:
- Microbiology and Virology
- Bacteriophage Therapy
- Antimicrobial Resistance
Background:
- Stenotrophomonas maltophilia is a significant cause of nosocomial infections, particularly in immunocompromised patients.
- The increasing antibiotic resistance of S. maltophilia poses a major clinical challenge.
- Bacteriophage therapy presents a promising alternative treatment strategy.
Purpose of the Study:
- To isolate, identify, and characterize a novel bacteriophage, designated CM1, targeting Stenotrophomonas maltophilia.
- To evaluate the physical, biochemical, and genomic properties of Stenotrophomonas phage CM1.
Main Methods:
- Isolation and identification of Stenotrophomonas phage CM1 from environmental samples.
- Morphological characterization using electron microscopy (head diameter, tail length, tail spikes).
- Determination of optimal growth conditions (pH, temperature stability, chloroform sensitivity).
- Genomic analysis including size, GC content, open-reading frame (ORF) identification, and phylogenetic analysis.
Main Results:
- Stenotrophomonas phage CM1, belonging to the Myoviridae family, exhibits a head diameter of ~224 nm and a tail length of ~159 nm with distinct tail spikes.
- The phage demonstrates optimal activity at pH 7, good thermal stability (37-60°C), and marginal infectivity loss in 1-5% chloroform.
- The phage genome is 319,518 bp with 43.9% GC content, containing 559 ORFs, including hypothetical proteins, known proteins, tRNAs, and a restriction enzyme. Phylogenetic analysis indicates a close relationship with other Stenotrophomonas phages.
Conclusions:
- Stenotrophomonas phage CM1 is a well-characterized bacteriophage with potential for therapeutic applications against S. maltophilia.
- Its distinct morphological and genomic features, along with its stability, support its candidacy for further development in phage therapy.
- The study contributes to the growing body of research on bacteriophages as a viable strategy to combat multidrug-resistant bacteria.
Related Concept Videos
DNA Bacteriophages
Modern Molecular Taxonomy
Lytic Cycle of Bacteriophages
Viral Replication: Lytic Cycle

